JP2018510131A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018510131A5 JP2018510131A5 JP2017539457A JP2017539457A JP2018510131A5 JP 2018510131 A5 JP2018510131 A5 JP 2018510131A5 JP 2017539457 A JP2017539457 A JP 2017539457A JP 2017539457 A JP2017539457 A JP 2017539457A JP 2018510131 A5 JP2018510131 A5 JP 2018510131A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- active metabolite
- pharmaceutically
- och
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562110060P | 2015-01-30 | 2015-01-30 | |
| US62/110,060 | 2015-01-30 | ||
| US201562267350P | 2015-12-15 | 2015-12-15 | |
| US62/267,350 | 2015-12-15 | ||
| PCT/IB2016/050477 WO2016120850A1 (en) | 2015-01-30 | 2016-01-29 | Sulfonamide-subsituted indole modulators of rorc2 and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018510131A JP2018510131A (ja) | 2018-04-12 |
| JP2018510131A5 true JP2018510131A5 (enExample) | 2019-06-20 |
Family
ID=55405379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017539457A Ceased JP2018510131A (ja) | 2015-01-30 | 2016-01-29 | Ｒｏｒｃ２のスルホンアミド置換インドールモジュレーターおよびその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10385036B2 (enExample) |
| EP (1) | EP3250561A1 (enExample) |
| JP (1) | JP2018510131A (enExample) |
| CA (1) | CA2975157C (enExample) |
| WO (1) | WO2016120850A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10336748B2 (en) | 2015-01-30 | 2019-07-02 | Pfizer Inc. | Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof |
| US20200087390A1 (en) | 2016-12-21 | 2020-03-19 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| GB201709456D0 (en) * | 2017-06-14 | 2017-07-26 | Ucb Biopharma Sprl | Therapeutic agents |
| KR102037494B1 (ko) | 2017-12-11 | 2019-10-28 | 씨제이헬스케어 주식회사 | 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법 |
| KR20190120112A (ko) | 2019-10-08 | 2019-10-23 | 씨제이헬스케어 주식회사 | 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법 |
| CN115322105A (zh) * | 2021-05-11 | 2022-11-11 | 江苏润安制药有限公司 | 一种合成艾拉莫德关键中间体的方法 |
| CN116135839A (zh) * | 2021-11-18 | 2023-05-19 | 江苏润安制药有限公司 | 一种阿齐沙坦关键中间体的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4742057A (en) | 1985-12-05 | 1988-05-03 | Fujisawa Pharmaceutical Co., Ltd. | Antiallergic thiazole compounds |
| GB9211276D0 (en) * | 1992-05-28 | 1992-07-15 | Glaxo Lab Sa | Pharmaceutical compositions |
| US5962473A (en) | 1996-08-16 | 1999-10-05 | Eli Lilly And Company | Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F |
| JP2001512727A (ja) | 1997-08-09 | 2001-08-28 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５ｈｔ−１受容体のリガンドとしてのニ環式化合物 |
| WO1999064044A1 (en) | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Novel therapeutic agents that modulate 5-ht receptors |
| MXPA03006605A (es) * | 2001-01-30 | 2003-09-22 | Lilly Co Eli | Esteres de indol-5-ilo del acido bencensulfonico como antagonistas del receptor 5-ht6. |
| JP6080846B2 (ja) | 2011-07-08 | 2017-02-15 | シンジェンタ パーティシペーションズ アーゲー | チエタンアミンの製造方法 |
| WO2014026330A1 (en) * | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| WO2014026328A1 (en) * | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof |
| WO2014026329A1 (en) * | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof |
| GEP20186876B (en) | 2013-08-02 | 2018-07-10 | Pfizer | Heterobicycloaryl rorc2 inhibitors and methods of use thereof |
| MA40759A (fr) | 2014-09-26 | 2017-08-01 | Pfizer | Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation |
| US10336748B2 (en) | 2015-01-30 | 2019-07-02 | Pfizer Inc. | Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof |
-
2016
- 2016-01-29 JP JP2017539457A patent/JP2018510131A/ja not_active Ceased
- 2016-01-29 US US15/547,228 patent/US10385036B2/en not_active Expired - Fee Related
- 2016-01-29 CA CA2975157A patent/CA2975157C/en not_active Expired - Fee Related
- 2016-01-29 WO PCT/IB2016/050477 patent/WO2016120850A1/en not_active Ceased
- 2016-01-29 EP EP16705819.7A patent/EP3250561A1/en not_active Withdrawn